Zhang Qian-qian, Fan Yu-ling, He Xiu-quan, Sun Yu-ming
Guang Pu Xue Yu Guang Pu Fen Xi. 2017 Jan;37(1):85-8.
Diabetes is a kind of diseases which does harm to people’s health, and the detection of human blood glucose levels utilizing blood samples will result in pain even infection for patients. Thus the in-vivo noninvasive measurement of human blood glucose levels has vital value in clinical diagnosis, detection and therapy, and it also is a very hot research topic with challenging. At present, as to various noninvasive detection methods, the technology based on mid-infrared absorption spectrophotometry with ATR has been gaining increasing attention. However, when carrying out noninvasive measurement of human blood glucose levels by means of the spectrophotometry equipped with routine light sources, the penetration depth of probe light in human tissues is low and thus it is very difficult to reach the stromal layer containing body fluids and especially dermis layer containing blood for probe light, which resulting in low relativity between experimental data and real human blood glucose levels and thus limiting the clinical application. Generally, not only the mid-infrared laser with high strength and high purity can deeper penetrate the human tissues, but also the output wavelengths at 1 035 cm(-1) of CO2 laser very coincide with the fundamental frequency characteristic absorption at 1 029 cm(-1) of glucose. Thus, in this work, a novel noninvasive mid-infrared measurement system to detect human blood glucose levels has been successfully assembled, in which a CO2 laser was used a self-defined external light source of the new mid-infrared absorption spectrophotometry with ATR. In this system, the absorbance of human fingertip at 1 035 cm(-1) has been measured when external CO2 laser source was used as probe light, at the same time, the mid-infrared absorption spectra of fingertip have been also obtained and absorbance at 1 492 cm(-1) has been recorded. The human blood glucose levels were determined synchronously by means of the routine medical method. The experimental results showed that the ratio in fingertip between absorbance at 1 035 cm(-1) from the laser source and one at 1 492 cm(-1) from mid-infrared absorption spectrophotometry could synchronously change with the human blood glucose levels, and the ratio presents certain positive relativity with the real human blood glucose levels(R=0. 812 5). Thus the measurement data could be used as a new index of blood glucose level in human body, which showed the potential in clinical diagnosis of the ATR mid-infrared absorption spectrophotometry with external CO(2) laser source in noninvasive measurement of human blood glucose levels.
糖尿病是一种危害人们健康的疾病,利用血样检测人体血糖水平会给患者带来疼痛甚至感染。因此,人体血糖水平的体内无创测量在临床诊断、检测和治疗中具有重要价值,也是一个极具挑战性的热门研究课题。目前,对于各种无创检测方法,基于衰减全反射(ATR)的中红外吸收分光光度法技术越来越受到关注。然而,当使用配备常规光源的分光光度计对人体血糖水平进行无创测量时,探测光在人体组织中的穿透深度较低,因此很难到达含有体液的基质层,尤其是含有血液的真皮层,这导致实验数据与实际人体血糖水平之间的相关性较低,从而限制了其临床应用。一般来说,不仅高强度、高纯度的中红外激光能够更深入地穿透人体组织,而且二氧化碳激光1035 cm⁻¹的输出波长与葡萄糖1029 cm⁻¹的基频特征吸收非常吻合。因此,在本研究中,成功组装了一种用于检测人体血糖水平的新型无创中红外测量系统,其中使用二氧化碳激光作为新型基于ATR的中红外吸收分光光度法的自定义外部光源。在该系统中,当使用外部二氧化碳激光源作为探测光时,测量了人体指尖在1035 cm⁻¹处的吸光度,同时还获得了指尖的中红外吸收光谱,并记录了1492 cm⁻¹处的吸光度。通过常规医学方法同步测定人体血糖水平。实验结果表明,来自激光源的1035 cm⁻¹处的吸光度与来自中红外吸收分光光度法的1492 cm⁻¹处的吸光度在指尖的比值能够随人体血糖水平同步变化,且该比值与实际人体血糖水平呈现一定的正相关(R = 0.8125)。因此,测量数据可作为人体血糖水平的新指标,这表明基于外部二氧化碳激光源的ATR中红外吸收分光光度法在人体血糖水平无创测量的临床诊断中具有潜力。